Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Interest Coverage Ratio: 2010-2017

Historic Interest Coverage Ratio for Corcept Therapeutics (CORT) over the last 1 years, with Jun 2017 value amounting to 56.87.

  • Corcept Therapeutics' Interest Coverage Ratio rose 5000.71% to 56.87 in Q2 2017 from the same period last year, while for Jun 2017 it was 33.31, marking a year-over-year increase of 61.38%. This contributed to the annual value of -1,293.28 for FY2011, which is 17.84% down from last year.
  • Corcept Therapeutics' Interest Coverage Ratio amounted to 56.87 in Q2 2017, which was up 5,000.71% from 1.11 recorded in Q2 2016.
  • Corcept Therapeutics' Interest Coverage Ratio's 5-year high stood at 56.87 during Q2 2017, with a 5-year trough of 1.11 in Q2 2016.
  • Moreover, its 2-year median value for Interest Coverage Ratio was 28.99 (2016), whereas its average is 28.99.
  • Data for Corcept Therapeutics' Interest Coverage Ratio shows a peak YoY skyrocketed of 5,000.71% (in 2017) over the last 5 years.
  • Over the past 2 years, Corcept Therapeutics' Interest Coverage Ratio (Quarterly) stood at 1.11 in 2016, then skyrocketed by 5,000.71% to 56.87 in 2017.
  • Its Interest Coverage Ratio stands at 56.87 for Q2 2017, versus 1.11 for Q2 2016 and -6,437.00 for Q3 2011.